Healthcare Industry News: Auxilium Pharmaceuticals
News Release - May 13, 2011
Rolf A. Classon Joins Board of EKR TherapeuticsBEDMINSTER, N.J.--(Healthcare Sales & Marketing Network)-- EKR Therapeutics, Inc., a privately held specialty pharmaceutical company focused on providing critical care products to the hospital marketplace, has announced that Rolf A. Classon has joined the Company as Chairman of the Board.
Mr. Classon brings to EKR the experiences of an outstanding international career in the pharmaceutical industry including senior roles at Pharmacia Biosystems, Miles Diagnostics, Bayer and Hill-Rom. He also currently serves as a Director of Auxilium Pharmaceuticals, Hill-Rom Holdings, Inc, Tecan Group, LTD, Prometheus Laboratories and Fresenius Medical Care.
“We are most fortunate to add Rolf to our Board. His rich experience and his ability to apply this to operational and strategic issues alike makes him extraordinarily valuable to our Company,” says John Bailye, CEO of EKR Therapeutics. “With Rolf’s addition, we are further prepared for substantial growth.”
About EKR Therapeutics, Inc
Since its inception, EKR has focused on acute-care hospital products and continues to actively pursue new opportunities in the hospital space. With its experienced field force of sales professionals, along with its commitment to excellence in customer service and medical education, EKR is leading the way as a provider of acute-care specialty products.
For additional information about EKR, visit the company’s website at www.ekrtx.com.
Source: EKR Therapeutics
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.